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T-VEC (Talimogene laherparepvec) is a local 
immunotherapy that contains a modified herpes virus with which 
a skin cancer can be cured. The invention of T-VEC can be called 
a breakthrough in medicine because it saves the lives of people 
who have inoperable stages III and IV of melanoma. 
Nowadays, a traditional chemotherapy is a thing of the 
past therefore, a new technique for using the virus is gaining 
popularity. An innovative drug was tested on 436 melanoma 
patients with different stages of cancer (IIIB, IIIC, IIID). At the 
end of the study, the research team concluded that 39% of the 
participants had a therapeutic response to T-VEC, which means 
that tumors in which administered the drug, completely 
disappeared. Another 18% of participants showed a significant 
decrease in the tumor, but not its complete disappearance. Thus, it 
is difficult to ignore 39% of the therapeutic response, so, scientists 
began to improve the drug so that soon every hopeless patient 
could get a chance for recovery. 
The action of the drug is based on the characteristic 
property of viruses to incorporate and then replicate their DNA in 
a human cell. T-VEC is injected directly into the tumor, where the 
modified herpes viruses infect cancer cells. They leave healthy 
cells because the modified herpes virus can only propagate inside 
cancer cells. Injection causes rupture of melanoma cells, thereby 
activating the immune system, which has already destroyed cancer 
cells independently without the help of the virus. The treatment is 
used every few weeks until the cancer disappears, which takes 
about four months. Importantly, this method is practically safe for 
humans, as evidenced by the fact that T-VEC is the only modified 
virus that the FDA has approved for treatment. 
T-VEC is an oncolytic herpes virus. Two genes were 
removed – one that shuts down an individual cell's defenses, and 
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another that helps the virus evade the immune system. The drug 
works by replicating in cancer cells, causing them to burst. 
Accordingly, with T-VEC, doctors have new options when 
choosing the treatment. This means that they do not need to 
remove the tumors surgically, and this will avoid many problems 
and postoperative complications. Oncolytic viruses are in clinical 
trials treating a broad array of malignancies including melanoma, 
sarcoma, carcinomas of the breast, lung, colon, prostate, kidney, 
liver pancreas, bladder and ovary. 
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Nowadays, obesity cannot be ignored no more, it is a 
major factor which is harmful for our human health. This 
metabolic illness results from excess accumulation of body fat. 
Obesity increases the development of such fatal diseases including 
diabetes mellitus, coronary heart disease, stroke, hypertension. 
Curing obese patients prevents the development of complications 
and irrevocable changes. Current therapeutic methods are 
maintaining a healthy lifestyle, a medical treatment, bypass 
surgery. 
Besides, the most effective treatment for obesity and type 
2 diabetes is a weight-loss surgery. However, only 1% of obese 
patients eligible for bypass surgery choose to undergo it. 
Therefore, the invention of less invasive and efficient method of 
